Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3SANOFI-AVENTIS US

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
BOS Manchester
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

RLD :

TE Code :

LIXISENATIDE

Brand Name : ADLYXIN

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 0.15MG/3ML (0.05MG/ML)

Approval Date :

Application Number : 208471

RX/OTC/DISCN :

RLD :

TE Code :

Sanofi Company Banner

02

arrow
BOS Manchester
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

RLD :

TE Code :

LIXISENATIDE

Brand Name : ADLYXIN

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 0.3MG/3ML (0.1MG/ML)

Approval Date :

Application Number : 208471

RX/OTC/DISCN :

RLD :

TE Code :

Sanofi Company Banner

03

arrow
BOS Manchester
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

RLD :

TE Code :

INSULIN GLARGINE; LIXISENATIDE

Brand Name : SOLIQUA 100/33

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 300 UNITS/3ML;99MCG/3ML (100 UNITS/ML;33MCG/ML)

Approval Date :

Application Number : 208673

RX/OTC/DISCN :

RLD :

TE Code :

Sanofi Company Banner